HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Perrigo's Svend Andersen Sees 'Revolutionary' Role For Digital Self-Care

Executive Summary

Digitalization, sustainability, CBD and probiotics are consumer health trends that Perrigo Plc’s executive vice president Svend Andersen considers in this wide-ranging exclusive interview with HBW Insight. 

You may also be interested in...



Bayer Consumer Health Sees Going Green As 'Good For Business'

Bayer Consumer Health's approach to sustainability is "baked into how we look at the business, how we think about the future of the company," says public affairs and sustainability head Daniella Foster. Companies looking to take a more proactive approach to sustainability should focus on their strengths and make targets measurable and accountable, Foster advises.

Perrigo Partners With Kazmira To Enter CBD Market

Perrigo has decided to enter the cannabidiol market in partnership with a known supplier of CBD products, Kazmira. The company has mapped out a two-phased approach for large scale production and supply of cGMP compliant, THC-free CBD.

Perrigo Takes $50M Step For US Consumer Health Industry Into CBD, Invests In Supplier Kazmira

Perrigo leads major consumer health companies into the CBD space with its $50m investment in Kazmira LLC, a Colorado business. The firm says the companies will lay groundwork for quality standards in the CBD market.

Topics

Latest News
UsernamePublicRestriction

Register

RS151309

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel